PFE Pfizer Inc.

NYSE
$26.79

Pfizer Inc. (PFE) is expected to report earnings on November 3, 2026, before the market open. The consensus earnings estimate is $0.79 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +7.0% since its last earnings release on August 4, 2026.

Pfizer Beat Expectations, Narrows Revenue Guidance
Tuesday, August 4, 2026 · 6:45 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 3
Tuesday · 6:45 AM ET
Earnings Whisper
-
vs $0.79
Rev est $16.11B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $26.34

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Pfizer Inc.

Pfizer Inc is a research-based biopharmaceutical company. The Company has five operating segments: Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health; and Consumer Healthcare.

Sector

Healthcare

Industry

Drug Manufacturers / Major